AI Verdict
HR has stronger fundamentals based on our AI analysis.
HRGN vs HR Fundamental Comparison
| Metric | HRGN | HR |
|---|---|---|
| Revenue | $704,000.0 | $1.2B |
| Net Income | $-6.9M | $-246.1M |
| Net Margin | -975.7% | -20.8% |
| ROE | -649.9% | -5.3% |
| ROA | -256.6% | -2.7% |
| Current Ratio | 1.19x | N/A |
| Debt/Equity | 0.00x | 0.85x |
| EPS | $-0.44 | $-0.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRGN vs HR: Frequently Asked Questions
Is HRGN or HR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HR has stronger fundamentals. HRGN is rated STRONG SELL (85% confidence) while HR is rated HOLD (72% confidence). This is not investment advice.
How does HRGN compare to HR fundamentally?
Harvard Apparatus Regenerative Technology, Inc. has ROE of -649.9% vs Healthcare Realty Trust Inc's -5.3%. Net margins are -975.7% vs -20.8% respectively.
Which stock pays higher dividends, HRGN or HR?
HRGN has a dividend yield of N/A or no dividend while HR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRGN or HR for long term?
For long-term investing, consider that HRGN has STRONG SELL rating with 85% confidence, while HR has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRGN vs HR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRGN vs HR, the AI consensus favors HR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.